![]() |
ASCO--for those running out of options, a new vinca alkaloid
(same drug class as vincristine) combined with herceptin active in Phase II trials
http://clinicaloptions.com/Oncology/...ules/1043.aspx |
first line only?
Not that it isn't good news, but this study was first line treatment for MBC. Could it be active in the heavily pretreated population I wonder?
|
| All times are GMT -7. The time now is 12:04 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021